43 Experience of the use of herbal medicinal product tonsilgon n in preschool children with waldeyer’s tonsillar ring medical condition

Study objective: to evaluate efficacy and safety of the use of the herbal medicinal product Tonsilgon N (HMP) in clinical practice in preschool children with Waldeyer’s tonsillar ring medical condition.Materials and Methods628 children (aged 2-5 years, median age – 3.34±2.78, girls – 316 (50.4%), bo...

Full description

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood 2021-10, Vol.106 (Suppl 2), p.A18-A18
Main Authors: Vavilova, Vera, Vavilov, Aleksandr M, Cherkayeva, Asya A, Nechayeva, Irina A, Bessonov, Kirill K
Format: Article
Language:English
Subjects:
Abstracts
Children
Herbal medicine
Hypertrophy
Lysozyme
Patient safety
Patients
Pediatrics
Pharynx
Preschool children
Rehabilitation
Respiration
Respiratory tract
Secretions
Side effects
Throat
Tonsil
Well being
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Study objective: to evaluate efficacy and safety of the use of the herbal medicinal product Tonsilgon N (HMP) in clinical practice in preschool children with Waldeyer’s tonsillar ring medical condition.Materials and Methods628 children (aged 2-5 years, median age – 3.34±2.78, girls – 316 (50.4%), boys – 312 (49.6%)) with chronic conditions of the pharyngeal and palatine tonsils were enrolled in the study. All children were divided into two comparable groups. Children in group I (n = 317) received HMP in drops during 60 days in overall.Preschoolers in the group II (n=311) did not receive HMP. Clinical efficacy and safety evaluation of the drug was performed before and after the treatment course.ResultsHMP therapy (group I) eliminated the signs of adenoiditis and led to a decrease in the number of children with second degree tonsil hypertrophy from 75.0–6.84% to 36.1–4.62% (p
ISSN:0003-9888
1468-2044
DOI:10.1136/archdischild-2021-europaediatrics.43